INmune Bio, Inc. - INMB Company Short-Term Debt

Graphic logo of INmune Bio, Inc. (INMB)

INmune Bio, Inc. (INMB) maintains a minimal environmental footprint due to the outsourcing of its production. The volume of short-term debt demonstrates current financial stability, where 0.00 describes the current status of the metric. The company is implementing advanced immune activation methods for the therapy of cancer and dementia. The proprietary XPro molecule creates a significant competitive advantage by selectively suppressing neuroinflammation in Alzheimer's disease.

INMB (INmune Bio Inc) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

INmune Bio Corporation - analytical breakdowns and key metrics (INMB)

- price and consensus price forecast:
Price Chart INmune Bio|INMB - Fair Value Consensus
- market capitalization data:
Market Value INmune Bio, Inc.|INMB - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share INmune Bio|INMB - Book Capitalization|Market Cap to Net Assets Ratio inmunebio.com|INMB - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital INmune Bio, Inc.|INMB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity INmune Bio, Inc.|INMB - Company Total Debt|Debt to Book Capitalization Ratio INmune Bio, Inc.|INMB - Company Long-Term Liabilities|Company Current Liabilities INmune Bio
Fundamental company valuation:INmune Bio - INMB
Product sample of INmune Bio, Inc.

The assessment of INmune Bio, Inc. (INMB) financial resilience to market shocks depends on liability management, as the development of cancer immunotherapy and Alzheimer's disease requires a constant influx of grants and investments. An analysis of the company's short-term credits and loans allows for tracking the cost of borrowed capital with maturities of up to one year, which helps investors assess liquidity risk between quarterly SEC reports.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|Company Short-Term Debts UPB (Upstream Bio Corp)|ZBIO: Short-Term Debt Volume|Company Short-Term Debt Immunome, Inc.|GOSS (gossamerbio.com) - Company Short-Term Indebtedness|Company Short-Term Debt KALV|Company Current Liabilities Septerna, Inc. (SEPN)|Company Current Liabilities PVLA|Company Short-Term Debts SVRA (Savara Pharma)|RIGL - Company Short-Term Debt|Company Short-Term Indebtedness anaptysbio.com ANAB|ATXS (Astria Therapeutics, Inc.) - Company Short-Term Debts|enGene Holdings Inc (ENGN) - Short-Term Debt|Company Current Liabilities RAPT Therapeutics RAPT|Aerovate Therapeutics (JBIO) - Company Short-Term Loans and Borrowings|Company Short-Term Debts Aclaris Therapeutics|Company Short-Term Debt kyvernatx.com|TLSA (Tiziana Life Sciences Ltd) - Company Short-Term Debts|Short-Term Debt Volume CABA (Cabaletta Bio Inc.)|VTYX: Company Short-Term Debt|THTX - Short-Term Debt|Company Current Liabilities Avalo Therapeutics, Inc (AVTX)|ELDN - Company Short-Term Loans and Borrowings|Agenus Inc. - Company Short-Term Debts|CLYM (Climb Bio Inc.) - Short-Term Debt Volume|Company Short-Term Debt Zura Bio (ZURA)|Company Short-Term Indebtedness aTyr Pharmaceuticals|Company Short-Term Debts ADAG (Adagene)|Company Current Liabilities ikenaoncology.com IMA|Company Current Liabilities STTK|Short-Term Debt Volume Equillium Inc EQ|Company Short-Term Debts CNTB (Connect Pharma)|IMUX: Short-Term Debt Volume|Company Short-Term Debt atarabio.com|IFRX (InflaRx) - Company Short-Term Indebtedness|Company Short-Term Debt XFOR|Company Current Liabilities Adicet|Company Short-Term Debts Celularity Inc. (CELU)|Company Short-Term Debt BRNS (Barinthus Biotherapeutics Corp)|Kezar Life Sciences (KZR) - Company Short-Term Debt|Current Liabilities sabbiotherapeutics.com SABS|Company Short-Term Debts Akari Therapeutics Plc (AKTX)|ENLV - Company Short-Term Loans and Borrowings|QTTB: Company Short-Term Debts|GOVX (GeoVax Corp) - Company Short-Term Debts|EDSA - Company Short-Term Debt|Company Short-Term Loans and Borrowings IBIO|Company Short-Term Debt CARM (Carisma Therapeutics)|Company Current Liabilities XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|HCWB - Company Short-Term Debts|Company Current Liabilities Aptevo (APVO)|AIM - Company Short-Term Loans and Borrowings|aditxt.com - Company Short-Term Debts|GRI (GRI Bio Inc) - Short-Term Debt Volume|Company Short-Term Debt XRTX|Company Current Liabilities HIND|Company Short-Term Debt REVB (Revelation Biosciences)|Company Current Liabilities indaptusrx.com INDP|Company Current Liabilities SCNI (Scinai Immunotherapeutics Ltd.)|CalciMedica Inc - Company Short-Term Debts|Affimed Therapeutics (AFMD) - Company Short-Term Debt|ALLK - Company Short-Term Indebtedness|Company Short-Term Debts HOOK|IGM Biosciences (IGMS) - Short-Term Debt|ITOS: Company Short-Term Debts|Short-Term Debt Volume OCEA|Company Short-Term Debt TC BioPharm (Holdings) PLC TCBP|Company Short-Term Indebtedness THRD (Third Harmonic Bio Inc)